XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.24.3

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES | 6 Months Ended
--- | ---
Sep. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
DERIVATIVES AND FAIR VALUE MEASUREMENTS | 13. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS The Company manufactures, markets and sells its products globally. During both the three and six months ended September 28, 2024, 25.9% of the Company’s sales were generated outside the U.S. in local currencies. The Company also incurs certain manufacturing, marketing and selling costs in international markets in local currency. Accordingly, earnings and cash flows are exposed to market risk from changes in foreign currency exchange rates relative to the U.S. Dollar, the Company’s reporting currency. The Company has a program in place that is designed to mitigate the exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the impact on its financial results from changes in foreign exchange rates. The Company utilizes foreign currency forward contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily Japanese Yen and Euro, and to a lesser extent, Swiss Franc and Mexican Peso. This does not eliminate the impact of the volatility of foreign exchange rates. However, because the Company generally enters into forward contracts one year out, rates are fixed for a one-year period, thereby facilitating financial planning and resource allocation. Designated Foreign Currency Hedge Contracts All of the Company’s designated foreign currency hedge contracts as of September 28, 2024 and March 30, 2024 were cash flow hedges under ASC 815, Derivatives and Hedging (“ASC 815”). The Company records the effective portion of any change in the fair value of designated foreign currency hedge contracts in other comprehensive income until the related third-party transaction occurs. Once the related third-party transaction occurs, the Company reclassifies the effective portion of any related gain or loss on the designated foreign currency hedge contracts to earnings. In the event the hedged forecasted transaction does not occur, or it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. The Company had designated foreign currency hedge contracts outstanding in the contract amount of $30.8 million as of September 28, 2024 and $74.0 million as of March 30, 2024. At September 28, 2024, a loss of $1.3 million, net of tax, will be reclassified to earnings within the next twelve months. All currency cash flow hedges outstanding as of September 28, 2024 mature within twelve months. Non-Designated Foreign Currency Contracts The Company manages its exposure to changes in foreign currency on a consolidated basis to take advantage of offsetting transactions and balances. It uses foreign currency forward contracts as a part of its strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These foreign currency forward contracts are entered into for periods consistent with currency transaction exposures, generally one month. They are not designated as cash flow or fair value hedges under ASC 815. These forward contracts are marked-to-market with changes in fair value recorded to earnings. The Company had non-designated foreign currency hedge contracts under ASC 815 outstanding in the contract amount of $38.0 million as of September 28, 2024 and $39.9 million as of March 30, 2024. Interest Rate Swaps Part of the Company’s interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company’s objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations. To mitigate the interest rate risk on the Company’s senior unsecured term loan, in September 2022, the Company entered into four interest rate swaps, two of which expired in June 2023 and the remaining two were amended and extended in September 2024. The amendment and extension of the two interest rate swaps did not have a material impact on the Condensed Consolidated Financial Statements. Loans under the 2024 Revised Credit Facilities bear interest at an annual rate equal to the 1-month USD Term SOFR, plus an applicable rate ranging from 1.125% to 1.750% based on the Company’s consolidated net leverage ratio. As a result of the amendment and extension in September 2024, the two modified interest rate swaps (the “Swaps”) have an average blended fixed interest rate of 3.31% plus the applicable rate on approximately 80% of the notional value of the unsecured term loan, until their maturity in April 2029. The Company has determined both of the Swaps are effective and qualify for hedge accounting treatment. The Company held the following interest rate swaps as of September 28, 2024:
Hedged Item |  | Original Notional Amount |  | Notional Amount as of September 28, 2024 |  | Designation Date |  | Effective Date |  | Termination Date |  | Fixed Interest Rate |  | Estimated Fair Value Assets (Liabilities)
(In thousands) |  |  |  |  |  |  |  |  |  |  |  |  |  |
1-month USD Term SOFR |  | 103,600 |  |  | 103,600 |  |  | 9/27/2024 |  | 9/30/2024 |  | 4/30/2029 |  | 3.32% |  | (634) |
1-month USD Term SOFR |  | 102,200 |  |  | 102,200 |  |  | 9/27/2024 |  | 9/30/2024 |  | 4/30/2029 |  | 3.30% |  | (403) |
Total |  | $ | 205,800 |  |  | $ | 205,800 |  |  |  |  |  |  |  |  |  |  | $ | (1,037) |
For the six months ended September 28, 2024, the Company recorded a loss of $2.1 million, net of tax, in accumulated other comprehensive loss to recognize the effective portion of the fair value of the swaps that qualify as cash flow hedges. Trade Receivables In the ordinary course of business, the Company grants trade credit to its customers on normal credit terms. In an effort to reduce its credit risk, the Company (i) establishes credit limits for all customers, (ii) performs ongoing credit evaluations of customers’ financial condition, (iii) monitors the payment history and aging of customers’ receivables, and (iv) monitors open orders against an individual customer’s outstanding receivable balance. The Company’s allowance for credit losses is maintained for trade accounts receivable based on the expected collectability, the historical collection experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. The Company has not experienced significant customer payment defaults, or identified other significant collectability concerns. The following is a roll forward of the allowance for credit losses:
| Three Months Ended |  | Six Months Ended
(In thousands) | September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
Beginning balance | $ | 5,719 |  |  | $ | 5,047 |  |  | $ | 5,695 |  |  | $ | 4,932 |
Credit loss | 179 |  |  | 30 |  |  | 216 |  |  | 181 |
Write-offs | 14 |  |  | (33) |  |  | 1 |  |  | (69) |
Ending balance | $ | 5,912 |  |  | $ | 5,044 |  |  | $ | 5,912 |  |  | $ | 5,044 |
Other Fair Value Measurements Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes the following three-level hierarchy used for measuring fair value: •Level 1 — Inputs to the valuation methodology are quoted market prices for identical assets or liabilities. •Level 2 — Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs. •Level 3 — Inputs to the valuation methodology are unobservable inputs based on management’s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk. The Company’s money market funds carried at fair value are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. Fair Value of Derivative Instruments The following table presents the effect of the Company’s derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its unaudited Condensed Consolidated Statements of Income and Comprehensive Income for the six months ended September 28, 2024:
Derivative Instruments |  | Amount of Gain Recognized in Accumulated Other Comprehensive Loss |  | Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings |  | Location in Condensed Consolidated Statements of Income and Comprehensive Income |  | Amount of Gain Excluded from Effectiveness Testing |  | Location in Condensed Consolidated Statements of Income and Comprehensive Income
(In thousands) |  |  |  |  |  |  |  |  |  |
Designated foreign currency hedge contracts, net of tax |  | $ | (1,263) |  |  | $ | (506) |  |  | Net revenues, COGS and SG&A |  | $ | 506 |  |  | Interest and other expense, net
Non-designated foreign currency hedge contracts |  | $ | — |  |  | $ | — |  |  |  |  | $ | 117 |  |  | Interest and other expense, net
Designated interest rate swaps, net of tax |  | $ | (2,053) |  |  | $ | 36 |  |  | Interest and other expense, net |  | $ | — |  |  |
The Company did not have fair value hedges or net investment hedges outstanding as of September 28, 2024 or March 30, 2024. As of September 28, 2024, no material deferred taxes were recognized for designated foreign currency hedges. ASC 815 requires all derivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by ASC 820, Fair Value Measurements and Disclosures, by considering the estimated amount it would receive or pay to sell or transfer these instruments at the reporting date and by taking into account current interest rates, currency exchange rates, current interest rate curves, interest rate volatilities, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company may utilize financial models to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; other observable inputs for the asset or liability; and inputs derived principally from, or corroborated by, observable market data by correlation or other means. As of September 28, 2024, the Company has classified its derivative assets and liabilities within Level 2 of the fair value hierarchy prescribed by ASC 815, as discussed below, because these observable inputs are available for substantially the full term of its derivative instruments. The following tables present the fair value of the Company’s derivative instruments as they appear in its Condensed Consolidated Balance Sheets as of September 28, 2024 and March 30, 2024:
(In thousands) |  | Location in Condensed Consolidated Balance Sheets |  | As of |  | As of
|  | September 28, 2024 |  | March 30, 2024
Derivative Assets: |  |  |  |  |  |
Designated foreign currency hedge contracts |  | Other current assets |  | $ | — |  |  | $ | 1,353 |
Non-designated foreign currency hedge contracts |  | Other current assets |  | 32 |  |  | 154 |
Designated interest rate swaps |  | Other current assets |  | 744 |  |  | 1,673 |
Designated interest rate swaps |  | Other long-term assets |  | — |  |  | 62 |
|  |  |  | $ | 776 |  |  | $ | 3,242 |
Derivative Liabilities: |  |  |  |  |  |
Designated foreign currency hedge contracts |  | Other current liabilities |  | $ | 624 |  |  | $ | 395 |
Non-designated foreign currency hedge contracts |  | Other current liabilities |  | 104 |  |  | 536 |
Designated interest rate swaps |  | Other long-term liabilities |  | 1,781 |  |  | — |
|  |  |  | $ | 2,509 |  |  | $ | 931 |
Fair Value Measured on a Recurring Basis Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of September 28, 2024 and March 30, 2024.
|  | As of September 28, 2024
(In thousands) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |
Money market funds |  | $ | 155,290 |  |  | $ | — |  |  | $ | — |  |  | $ | 155,290 |
Non-designated foreign currency hedge contracts |  | — |  |  | 32 |  |  | — |  |  | 32 |
Designated interest rate swaps |  | — |  |  | 744 |  |  | — |  |  | 744 |
|  | $ | 155,290 |  |  | $ | 776 |  |  | $ | — |  |  | $ | 156,066 |
Liabilities |  |  |  |  |  |  |  |
Designated foreign currency hedge contracts |  | $ | — |  |  | $ | 624 |  |  | $ | — |  |  | $ | 624 |
Non-designated foreign currency hedge contracts |  | — |  |  | 104 |  |  | — |  |  | 104 |
Designated interest rate swaps |  | — |  |  | 1,781 |  |  | — |  |  | 1,781 |
Contingent consideration |  | — |  |  | — |  |  | 26,334 |  |  | 26,334 |
|  | $ | — |  |  | $ | 2,509 |  |  | $ | 26,334 |  |  | $ | 28,843 |
|  | As of March 30, 2024
|  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |
Money market funds |  | $ | 43,073 |  |  | $ | — |  |  | $ | — |  |  | $ | 43,073 |
Designated foreign currency hedge contracts |  | — |  |  | 1,353 |  |  | — |  |  | 1,353 |
Non-designated foreign currency hedge contracts |  | — |  |  | 154 |  |  | — |  |  | 154 |
Designated interest rate swaps |  | — |  |  | 1,735 |  |  | — |  |  | 1,735 |
|  | $ | 43,073 |  |  | $ | 3,242 |  |  | $ | — |  |  | $ | 46,315 |
Liabilities |  |  |  |  |  |  |  |
Designated foreign currency hedge contracts |  | $ | — |  |  | $ | 395 |  |  | $ | — |  |  | $ | 395 |
Non-designated foreign currency hedge contracts |  | — |  |  | 536 |  |  | — |  |  | 536 |
|  | $ | — |  |  | $ | 931 |  |  | $ | — |  |  | $ | 931 |
Foreign currency hedge contracts - The fair value of foreign currency hedge contracts was measured using significant other observable inputs and valued by reference to over-the-counter quoted market prices for similar instruments. The Company does not believe that the fair value of these derivative instruments differs significantly from the amount that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows. Interest rate swaps - The fair values of interest rate swaps are measured using the present value of expected future cash flows using market-based observable inputs, including credit risk and interest rate yield curves. The Company does not believe that the fair values of these derivative instruments differ significantly from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows. Contingent consideration - The fair value of contingent consideration liabilities is based on significant unobservable inputs, including management estimates and assumptions, and is measured based on the probability-weighted present value of the payments expected to be made. Accordingly, the fair value of contingent consideration has been classified as level 3 within the fair value hierarchy. The level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:
|  | Fair Value at |  | Valuation |  | Unobservable |  |
(In thousands) |  | September 28, 2024 |  | Technique |  | Input |  | Range
Revenue-based payments |  | $ | 20,606 |  |  | Monte Carlo Simulation Model |  | Discount rate |  | 6.3%
|  |  | Projected year of payments |  | 2025 - 2027
Regulatory-based payment |  | $ | 4,735 |  |  | Monte Carlo Simulation Model |  | Discount rate |  | 6.1%
|  |  | Probability of payment |  | 50%
|  |  | Projected year of payment |  | 2026 - 2028
Event-based payment |  | $ | 993 |  |  | Monte Carlo Simulation Model |  | Discount rate |  | 5.8%
|  |  | Projected year of payment |  | 2028
The fair value of contingent consideration associated with the Attune Medical acquisition was $26.3 million at September 28, 2024. As of September 28, 2024, $8.0 million was included in other current liabilities and $18.3 million was included in other long-term liabilities on the Condensed Consolidated Balance Sheets. A reconciliation of the change in the fair value of contingent consideration is included in the following table:
(In thousands) |  |
Balance at March 30, 2024 |  | $ | — |
Acquisition date fair value of contingent consideration |  | 25,000 |
Purchase accounting adjustments |  | 300 |
Change in fair value |  | 1,034 |
Balance at September 28, 2024 |  | $ | 26,334 |
Other Fair Value Disclosures The fair values of the 2026 Notes and 2029 Notes were $277.7 million and $701.7 million as of September 28, 2024, respectively, which were determined by using the market price on the last trading day of the reporting period and are considered as level 2 in the fair value hierarchy. The senior unsecured term loan (which is carried at amortized cost), accounts receivable and accounts payable approximate fair value.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivatives and fair value of assets and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/815/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/820/tableOfContent + Details
Name: | us-gaap_DerivativesAndFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration